DiNuzzo Private Wealth Inc. bought a new position in shares of Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,291 shares of the biopharmaceutical company’s stock, valued at approximately $37,000. Several other institutional […]
Auxano Advisors LLC purchased a new position in shares of Ashland Inc. (NYSE:ASH – Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm purchased 9,707 shares of the basic materials company’s stock, valued at approximately $818,000. Other institutional investors have also recently made changes to their positions […]
Meritage Portfolio Management bought a new position in shares of Fiserv, Inc. (NYSE:FI – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 7,493 shares of the business services provider’s stock, valued at approximately $995,000. A number of other large […]
Bfsg LLC acquired a new stake in Ally Financial Inc. (NYSE:ALLY – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 6,975 shares of the financial services provider’s stock, valued at approximately $244,000. Other institutional investors and hedge funds have also modified their […]
Stevens Capital Management LP bought a new stake in Rockwell Automation, Inc. (NYSE:ROK – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 2,489 shares of the industrial products company’s stock, valued at approximately $773,000. Other institutional investors have also modified […]
John G Ullman & Associates Inc. trimmed its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 29.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 407,708 shares of the biopharmaceutical company’s stock after selling 169,128 shares during the quarter. Pfizer […]
K.J. Harrison & Partners Inc acquired a new position in shares of Broadcom Inc. (NASDAQ:AVGO – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 500 shares of the semiconductor manufacturer’s stock, valued at approximately $558,000. Other […]
Cutter & CO Brokerage Inc. increased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 473.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 104,331 shares of the biopharmaceutical company’s stock after purchasing an additional 86,137 shares during the […]
Mountain Pacific Investment Advisers Inc. ID purchased a new position in shares of Starbucks Co. (NASDAQ:SBUX – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 2,092 shares of the coffee company’s stock, valued at approximately $201,000. Other institutional investors have […]
Consolidated Planning Corp lessened its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 36.6% during the 4th quarter, HoldingsChannel.com reports. The fund owned 9,782 shares of the biopharmaceutical company’s stock after selling 5,645 shares during the period. Consolidated Planning Corp’s holdings in Pfizer were worth $282,000 as of its most recent filing with the […]
Certuity LLC purchased a new position in American Tower Co. (NYSE:AMT – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,089 shares of the real estate investment trust’s stock, valued at approximately $235,000. Several other large […]
Private Wealth Partners LLC lessened its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 9.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 425,358 shares of the biopharmaceutical company’s stock after selling 43,646 shares during the quarter. Pfizer comprises 1.0% of Private Wealth […]